Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Clarifying haplotype ambiguity of NAT2 in multi-national cohorts.

Selinski S, Blaszkewicz M, Agundez JA, Martinez C, Garcia-Martin E, Hengstler JG, Golka K.

Front Biosci (Schol Ed). 2013 Jan 1;5:672-84.

PMID:
23277078
[PubMed - indexed for MEDLINE]
2.

Reconstruction of N-acetyltransferase 2 haplotypes using PHASE.

Golka K, Blaszkewicz M, Samimi M, Bolt HM, Selinski S.

Arch Toxicol. 2008 Apr;82(4):265-70. Epub 2007 Sep 19.

PMID:
17879084
[PubMed - indexed for MEDLINE]
3.

Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in shanghai population: occupational and non-occupational bladder cancer patient groups.

Ma QW, Lin GF, Chen JG, Xiang CQ, Guo WC, Golka K, Shen JH.

Biomed Environ Sci. 2004 Sep;17(3):291-8.

PMID:
15602826
[PubMed - indexed for MEDLINE]
4.

Unraveling ambiguous NAT2 genotyping data.

Agúndez JA, Golka K, Martínez C, Selinski S, Blaszkewicz M, García-Martín E.

Clin Chem. 2008 Aug;54(8):1390-4. doi: 10.1373/clinchem.2008.105569.

PMID:
18664443
[PubMed - indexed for MEDLINE]
Free Article
5.

Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.

Selinski S, Blaszkewicz M, Ickstadt K, Hengstler JG, Golka K.

Arch Toxicol. 2013 Dec;87(12):2129-39. doi: 10.1007/s00204-013-1157-7. Epub 2013 Nov 13.

PMID:
24221535
[PubMed - indexed for MEDLINE]
6.

A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background.

García-Closas M, Hein DW, Silverman D, Malats N, Yeager M, Jacobs K, Doll MA, Figueroa JD, Baris D, Schwenn M, Kogevinas M, Johnson A, Chatterjee N, Moore LE, Moeller T, Real FX, Chanock S, Rothman N.

Pharmacogenet Genomics. 2011 Apr;21(4):231-6. doi: 10.1097/FPC.0b013e32833e1b54.

PMID:
20739907
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.

Taylor JA, Umbach DM, Stephens E, Castranio T, Paulson D, Robertson C, Mohler JL, Bell DA.

Cancer Res. 1998 Aug 15;58(16):3603-10.

PMID:
9721868
[PubMed - indexed for MEDLINE]
Free Article
8.

Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.

Gu J, Liang D, Wang Y, Lu C, Wu X.

Mutat Res. 2005 Mar 7;581(1-2):97-104. Epub 2004 Dec 16.

PMID:
15725609
[PubMed - indexed for MEDLINE]
9.

An unlikely role for the NAT2 genotypes and haplotypes in the oral cancer of south Indians.

Balaji L, Krishna BS, Bhaskar LV.

Arch Oral Biol. 2012 May;57(5):513-8. doi: 10.1016/j.archoralbio.2011.10.019. Epub 2011 Dec 2.

PMID:
22137356
[PubMed - indexed for MEDLINE]
10.

N-acetyltransferase 2 polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity in Caucasians.

Leiro-Fernandez V, Valverde D, Vázquez-Gallardo R, Botana-Rial M, Constenla L, Agúndez JA, Fernández-Villar A.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1403-8. doi: 10.5588/ijtld.10.0648.

PMID:
22283902
[PubMed - indexed for MEDLINE]
11.

The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences.

Golka K, Prior V, Blaszkewicz M, Bolt HM.

Toxicol Lett. 2002 Mar 10;128(1-3):229-41. Review.

PMID:
11869833
[PubMed - indexed for MEDLINE]
12.

Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.

Cascorbi I, Roots I, Brockmöller J.

Cancer Res. 2001 Jul 1;61(13):5051-6.

PMID:
11431340
[PubMed - indexed for MEDLINE]
Free Article
13.

N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort.

Pesch B, Gawrych K, Rabstein S, Weiss T, Casjens S, Rihs HP, Ding H, Angerer J, Illig T, Klopp N, Bueno-de-Mesquita B, Ros MM, Kaaks R, Chang-Claude J, Roswall N, Tjønneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Dossus L, Boeing H, Weikert S, Trichopoulos D, Palli D, Sieri S, Tumino R, Panico S, Quirós JR, González C, Sánchez MJ, Dorronsoro M, Navarro C, Barricarte A, Ljungberg B, Johansson M, Ulmert D, Ehrnström R, Khaw KT, Wareham N, Key TJ, Ferrari P, Romieu I, Riboli E, Brüning T, Vineis P.

Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2055-65. doi: 10.1158/1055-9965.EPI-13-0119-T. Epub 2013 Oct 3.

PMID:
24092628
[PubMed - indexed for MEDLINE]
14.

NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese.

Inatomi H, Katoh T, Kawamoto T, Matsumoto T.

Int J Urol. 1999 Sep;6(9):446-54. Erratum in: Int J Urol 1999 Nov;6(11):592.

PMID:
10510890
[PubMed - indexed for MEDLINE]
15.

Comparison of genetic polymorphisms of the NAT2 gene between Korean and four other ethnic groups.

Kang TS, Jin SK, Lee JE, Woo SW, Roh J.

J Clin Pharm Ther. 2009 Dec;34(6):709-18. doi: 10.1111/j.1365-2710.2009.01065.x.

PMID:
20175805
[PubMed - indexed for MEDLINE]
16.

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Castaño-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Torà M, Fernández F, Real FX, Rothman N.

Lancet. 2005 Aug 20-26;366(9486):649-59.

PMID:
16112301
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients.

Schnakenberg E, Ehlers C, Feyerabend W, Werdin R, Hübotter R, Dreikorn K, Schloot W.

Clin Genet. 1998 May;53(5):396-402.

PMID:
9660060
[PubMed - indexed for MEDLINE]
18.

N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.

Hein DW.

Oncogene. 2006 Mar 13;25(11):1649-58. Review.

PMID:
16550165
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

 NAT2 genetic polymorphisms and anti-tuberculosis drug-induced hepatotoxicity in Chinese community population.

Lv X, Tang S, Xia Y, Zhang Y, Wu S, Yang Z, Li X, Tu D, Chen Y, Deng P, Ma Y, Chen D, Chen R, Zhan S.

Ann Hepatol. 2012 Sep-Oct;11(5):700-7.

PMID:
22947533
[PubMed - indexed for MEDLINE]
20.

Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma.

Mahid SS, Colliver DW, Crawford NP, Martini BD, Doll MA, Hein DW, Cobbs GA, Petras RE, Galandiuk S.

BMC Med Genet. 2007 May 30;8:28.

PMID:
17537267
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk